Overview

As one of the most massive and successful business sectors, the pharmaceutical industry is a potent force for good in the community, yet its behaviour is frequently questioned: could it serve society at large better than it has done in the recent past? Its own internal ethics, both in business and science, may need a careful reappraisal, as may the extent to which the law - administrative, civil and criminal - succeeds in guiding (and where neccessary contraining) it. The rules of behavior that may be considered to apply to today's pharmaceutical industry have emerged over a very long period and the process goes on. Even the immensely detailed standards for quality, safety and efficacy laid down in drug law and regulation during the second half of the twentieth century have their limitations as tools for ensuring that the public interest is well served. In particular, national and regional regulatory agencies are heavily dependent on industrial data for their decision-making, their standards and competence vary, and even the existing network of agencies does not cover the entire world. What is more there are many areas of law and regulation affecting the industry, concerning for example the pricing of medicines, the conduct of clinical studies, the health protection of workers and concern for the environment. In some fields it is indeed hardly possible to maintain standards through regulation.Professor N.M. Graham Dukes, a physician and lawyer with long term experience in industrial research management, academic study and international drug policy, provides here a powerfully documented analysis into the way this industry thinks, acts, and is viewed, and examines the current trends pointing to change.

Full Product Details

Author:   M.N.G. Dukes (Oslo, Norway)
Publisher:   Elsevier Science & Technology
Imprint:   Elsevier Science Ltd
Dimensions:   Width: 16.50cm , Height: 2.20cm , Length: 24.00cm
Weight:   0.930kg
ISBN:  

9780444518682

ISBN 10:   0444518681
Pages:   422
Publication Date:   04 November 2005
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   In Print  
Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock.

Table of Contents

PREFACE ACKNOWLEDGEMENTS PART A: THE DEFINITION OF STANDARDS 1. INTRODUCTION: THE PHARMACEUTICAL INDUSTRY AND ITS PRODUCTS 2. SOURCES OF STANDARDS FOR BUSINESS AND INDUSTRY 3. SOURCES OF STANDARDS SPECIFIC TO THE PHARMACEUTICAL INDUSTRY PART B: ACCEPTANCE AND IMPLEMENTATION OF STANDARDS 4. THE INDUSTRY AS A DEVELOPER, MANUFACTURER AND SUPPLIER 5. THE INDUSTRY AS A SOURCE OF INFORMATION, PERSUASION AND EDUCATION 6. PHARMACEUTICAL PRICING AND PROFITS 7. THE INDUSTRY AS INNOVATOR 8. THE INDUSTRY AND THE DEVELOPING WORLD 9. SPECIAL SITUATIONS 10. THE DUTIES OF THE GENERIC MANUFACTURER 11. THE PHARMACEUTICAL INDUSTRY AND SOCIAL CONTROVERSY 12. POSTSCRIPT: THE WAY AHEAD SELECTED REFERENCES

Reviews

...Although Dukes doesn't attempt to catalogue all relevant laws, he provides categories and examples that serve as a useful starting point for understanding the types of policies and laws that should be considered in particular cases. In addition, Dukes includes stories that led to the adoption of some of the laws and policies, which helps to make the process more accessible to the reader. - Jeremy Sugarman, M.D., M.P.H., Johns Hopkins University for THE NEW ENGLAND JOURNAL OF MEDICINE(2006) ...a measured walk through most of the beter-known public policy issues revolving around drug research, marketing and use. - PharmaceuticalCommerce.com (2006)

...includes stories that led to the adoption of some of the laws and policies, which helps to make the process more accessible... - Jeremy Sugarman, M.D., M.P.H., Johns Hopkins University for THE NEW ENGLAND JOURNAL OF MEDICINE(2006) ...a measured walk through most of the beter-known public policy issues revolving around drug research, marketing and use. - PharmaceuticalCommerce.com (2006)

...Although Dukes doesn't attempt to catalogue all relevant laws, he provides categories and examples that serve as a useful starting point for understanding the types of policies and laws that should be considered in particular cases. In addition, Dukes includes stories that led to the adoption of some of the laws and policies, which helps to make the process more accessible to the reader. - Jeremy Sugarman, M.D., M.P.H., Johns Hopkins University for THE NEW ENGLAND JOURNAL OF MEDICINE(2006) ...a measured walk through most of the beter-known public policy issues revolving around drug research, marketing and use. - PharmaceuticalCommerce.com (2006)

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions